Abstract:Objective To detect the expression of peripheral blood free prostate specific antigen (fSPA),total prostate specific antigen (tSPA),prostate specific antigen density (PSAD) and prostate cancer gene 3 (PCA3) in prostate disease,and the significance of combined detection of fSPA,tSPA and PCA3.Methods 67 patients with prostate cancer,75 patients with prostatic hyperplasia and 70 healthy male were selected as the research objects from Dec.2014 to Jul.2016.The serum level of fSPA and tSPA was detected by chemiluminescence immune staining method.The prostate volume was tested by ultrasonic sound and PSAD value was calculated.The total RNA was extracted by Trizol,and the serum PCA3 mRNA expression was detected by RT-PCR.The specificity and sensitivity of combined detection of fSPA,tSPA and PCA3 were analyzed.Results The serum levels of fSPA,tSPA,PSAD and PCA3 in prostate cancer were significantly higher than those in patients with prostatic hyperplasia and healthy male,and they were higher in patients with hyperplasia of prostate than in healthy male,and the differences had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were higher in patients with Gleason score ≥7 points and in T3-T4 stage than in patients with Gleason score ＜7 and in T1-T2 stage,and the difference had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were positively correlated with Gleason score and TMN pathological stage,and the difference had statistical significance (P＜0.01).The AUC value of fSPA,tSPA,PSAD and PCA3 in diagnosis of prostate cancer was 0.53,0.57,0.63 and 0.75,and the AUC value of combined detection was 0.92.The combined detection efficiency was higher than the single index.The specificity of fSPA,tSPA,PSAD and PCA3 was 67.16％,68.66％,73.13％ and 85.07％,and the sensitivity was 71.64％,70.15％,74.63％ and 82.09％ respectively.The specificity of combined detection was 97.01％,the sensitivity was 92.54％,and the difference had statistical significance (P＜0.01).Conclusion The serum level of fSPA,tSPA,PSAD and PCA3 is increased in prostate disease,and is negatively correlated with Gleason score and TMN pathological stage.The combined detection of fSPA,tSPA,PSAD and PCA3 can improve the sensitivity and specificity of prostate disease diagnosis,and is of high clinical value.

[Identification of Low-Molecular Weight Prostate-Specific Antigen(psa) and Lactoferrin in the Prostatic Secretion of Benign Prostatic Hyperplasia].

Urinary Microbiota In Patients With Prostate Cancer And Benign Prostatic Hyperplasia

Effect of Hypertension on Bacteria Composition of Prostate Biopsy in Patients with Benign Prostatic Hyperplasia and Prostate Cancer in PSA Grey-Zone.

Identification of a Specifically Expressed Modified Form of Novel PSP‐94 Protein in the Secretion of Benign Prostatic Hyperplasia

Expression ofαs1-casein in benign prostatic hyperplasias

Expression of αs1-casein in benign prostatic hyperplasias

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates.

Comparison of oligonucleotide-labeled antibody probe assays for prostate-specific antigen detection.

Applied Research of Prostate Specific Antigen Combined with Prostate Cancer Gene 3 in Diagnosis of Prostate Disease

Correlation Between EPS Leukocyte Count and Elevated Serum PSA in Benign Prostatic Hyperplasia Patients

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

[Clinical Significance of Prostatic-Specific Antigen Levels in Patients with Benign Prostatic Hyperplasia Complicated by Low Urinary Tract Syndrome].

Structural alterations and significance of sugar chains of PSA in urine and blood from BPH and Pca patients

Molecular Heterogeneity of Free PSA in Sera of Patients with Benign and Malignant Prostate Tumors

Distribution characteristics of leukocytes in EPS and correlation with serum PSA levels: results from a Chinese male population survey

Relationship Between Interleukin-8 Levels in Expressed Prostatic Secretion and Expressions of Bfgf and Bcl-2 in Benign Prostatic Hyperplasia

The expression of PSP94 in the tissues of benign prostatic hyperplasia and prostate cancer

Characterisation of the Bacterial Community in Expressed Prostatic Secretions from Patients with Chronic Prostatitis/chronic Pelvic Pain Syndrome and Infertile Men: a Preliminary Investigation.

Changes and clinilcal significances of serum total prostate-specific antigen,free prostate-specific antigen and free/total prostate-specific antigen in patients with benign and malignant prostatic diseases

Identification of Candidate Prostate Cancer Biomarkers in Prostate Needle Biopsy Specimens Using Proteomic Analysis.